RoadMAP/UK launch!

After a bit of disruption by the events of 2020 and the Covid-19 pandemic, we are pleased to announce that we’re back and launching a new community outreach and engagement activity: RoadMAP/UK.

RoadMAP/UK consists of three parts. The first is an educational briefing consisting of nine short video tutorials which aims to provide a foundation of knowledge of the core concepts in applied metabolic phenotyping. The second part is a survey which will help us understand your interests and priorities for the successful application of metabolic phenotyping within your own research. The third part is a follow-up discussion which will review and build on what we’ve collectively learned from the survey data, allowing for more detailed discussion around key topics of interest. Ultimately, our hope is to be able to use our existing capabilities and align our novel capability development activities to meet the needs of the UK biomedical research community. This listening activity is a critical step forward in that process.

MAP/UK Goes Live!

Following the successful Kickoff of the MAP/UK Partnership, our website and twitter feed are now live. Follow us @MAPUK_Partners!

Kickoff_Group.jpg

The MRC Funds MAP/UK

Bringing together major UK institutions and specialists in diverse areas of analytical chemistry and human disease research, the on the 25th of January, 2019, the MRC awarded funds to the MAP/UK partnership. It is envisioned that this investment in UK science will create a core capability for delivering high quality metabolic phenotyping data to academics, clinicians and industry to serve the emerging priority area of population phenotyping. Ultimately it is expected that this UK partnership will provide the network, tools and expertise to improve understanding of lifetime disease risks, provide a framework for making collective decisions for future disease and healthcare roadmaps and inform future global public health policies. We anticipate that bringing together the partners and collaborators to define UK metabolic phenotyping practices will significantly advance the UK’s global leadership in the field.